Peginterferon ??-2a (40KD) Plus Ribavirin
- 1 January 2005
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 65 (4) , 521-536
- https://doi.org/10.2165/00003495-200565040-00006
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Viral Kinetics During Antiviral Therapy in Patients With Chronic Hepatitis C and Persistently Normal Alt LevelsHepatology, 2004
- Diagnosis, management, and treatment of hepatitis C†Hepatology, 2004
- Ribavirin inhibits DNA, RNA, and protein synthesis in PHA‐stimulated human peripheral blood mononuclear cells: Possible explanation for therapeutic efficacy in patients with chronic HCV infectionJournal of Medical Virology, 2002
- Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative studyHepatology, 2002
- The single dose pharmacokinetics of ribavirin in subjects with chronic liver diseaseBritish Journal of Clinical Pharmacology, 2000
- Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activityHepatology, 1998
- Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: A multicenter trialHepatology, 1997
- Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled studyJournal of Hepatology, 1996
- Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis CJournal of Medical Virology, 1993
- A Pilot Study of Ribavirin Therapy for Chronic Hepatitis CHepatology, 1992